Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts
Bryce D. Beseth(University of California, Los Angeles), Raj K. Puri(Integrated BioTherapeutics (United States)), Robert B. Cameron(University of California, Los Angeles), Frederick Varricchio(Rutgers, The State University of New Jersey), Richard A. Maki(Neurocrine Biosciences (United States)), David M. Jablons(City College of San Francisco), Syed R. Husain(Center for Biologics Evaluation and Research), Pamela Leland, Liang You(University of Toledo Medical Center), Robert J. Kreitman(National Cancer Institute)
Cited by 8
Related Papers
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
|Nature Biotechnology|2006|2.2k
The balance of reproducibility, sensitivity, and specificity of lists of differentially expressed genes in microarray studies
|BMC Bioinformatics|2008|404
Understanding vaccine safety information from the Vaccine Adverse Event Reporting System
|The Pediatric Infectious Disease Journal|2004|381
Immunotoxins for targeted cancer therapy
|The AAPS Journal|2006|307